1. Home
  2. FULC vs FRAF Comparison

FULC vs FRAF Comparison

Compare FULC & FRAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fulcrum Therapeutics Inc.

FULC

Fulcrum Therapeutics Inc.

SELL

Current Price

$3.67

Market Cap

285.4M

Sector

Health Care

ML Signal

SELL

Logo Franklin Financial Services Corporation

FRAF

Franklin Financial Services Corporation

SELL

Current Price

$63.06

Market Cap

279.0M

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
FULC
FRAF
Founded
2015
1906
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
285.4M
279.0M
IPO Year
2019
1995

Fundamental Metrics

Financial Performance
Metric
FULC
FRAF
Price
$3.67
$63.06
Analyst Decision
Hold
Analyst Count
5
0
Target Price
★ $3.67
N/A
AVG Volume (30 Days)
★ 1.4M
26.4K
Earning Date
10-28-2026
10-27-2026
Dividend Yield
N/A
★ 2.17%
EPS Growth
N/A
★ 88.84
EPS
N/A
★ 2.94
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$6.58
P/E Ratio
★ N/A
$21.36
Revenue Growth
N/A
N/A
52 Week Low
$2.83
$43.97
52 Week High
$15.74
$65.41

Technical Indicators

Market Signals
Indicator
FULC
FRAF
Relative Strength Index (RSI) 39.62 47.78
Support Level $3.62 $60.39
Resistance Level $3.91 $64.44
Average True Range (ATR) 0.06 1.47
MACD -0.00 -0.02
Stochastic Oscillator 11.11 49.65

Price Performance

Historical Comparison
FULC
FRAF

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing small molecules for genetically defined rare diseases. Its product candidate, Pociredir, is an oral small molecule designed to induce fetal hemoglobin (HbF) and is in clinical development for sickle cell disease (SCD). The company completed dosing in the Phase 1b PIONEER trial evaluating pociredir in adults with SCD and reported clinical data showing clinically relevant HbF induction and improvements in markers of hemolysis and anemia. The company has also generated a pipeline of clinical-stage and pre-clinical programs targeting the root causes of rare genetic diseases.

About FRAF Franklin Financial Services Corporation

Franklin Financial Services Corp is a bank holding company based in the United States. It is engaged in general commercial, retail banking, and trust services normally associated with community banks. It offers a broad range of banking services to businesses, individuals, and governmental entities, which include accepting and maintaining cheques, savings, and time deposit accounts, providing investment and trust services, making loans and providing safe deposit facilities. The bank also performs personal, corporate, pension and fiduciary services through its Investment and Trust Services Department.

Share on Social Networks: